← Back to the catalogue
Amino acids
Glutamate
Amino acid at the crossroads between nitrogen handling and cellular metabolism. It is also the main excitatory neurotransmitter of the central nervous system and a precursor of glutamine and GABA.
Application contexts
- Metabolism and nutrition
Matrices
- Faeces
- Breast milk
- Tissues · muscle and liver
- Serum or plasma
Related techniques
- ¹H-NMR
Related publications
- Metabolomics Approach to Identify Biomarkers of Acute and Subacute Mastitis in Milk Samples: A Pilot Case-Control Study. 2024 · Metabolites · 4 citations
- Assessment of physical status and analysis of lipidomic and metabolomic alterations in patients with Post-COVID-19 condition. 2026 · PloS one · 1 citation
Related news
- NMR Metabolomics in Animal Models: A Key Tool for Translational Research 10 April 2025 · Panel: NMR low-molecular-weight metabolites
- Metabolomics in Sports: Applications in Performance and Recovery 24 October 2024 · Panel: NMR low-molecular-weight metabolites
- Role of Metabolomics in Infectious Diseases: A Cross-sectional Approach 19 September 2024 · Panel: NMR low-molecular-weight metabolites
Show 7 more Show less
- Desvelando Misterios de la Complejidad Lipoproteica en Diabetes Tipo 2 y Riesgo Cardiovascular 29 April 2024 · in Spanish · Panel: NMR low-molecular-weight metabolites
- Biosfer Teslab at the forefront of NMR sample analysis 26 March 2024 · Panel: NMR low-molecular-weight metabolites
- Exploring Metabolomics through Nuclear Magnetic Resonance and its Impact on Nutritional Interventions 13 February 2024 · Panel: NMR low-molecular-weight metabolites
- The Importance of Branched-Chain Amino Acids (BCAAs) in Metabolism Monitoring 08 February 2024 · Panel: NMR low-molecular-weight metabolites
- MetBalance test: Monitor your metabolic health and revolutionize the way you take care of yourself 29 January 2024 · Panel: NMR low-molecular-weight metabolites
- What is metabolomics and how is it applied in diabetes? 13 November 2023 · Panel: NMR low-molecular-weight metabolites
- Liposcale for early and reliable diagnosis and prognosis of breast cancer patients 08 September 2021 · Panel: NMR low-molecular-weight metabolites
Related projects
- DALÍ 2024 · Consortium coordinator · Panel: NMR low-molecular-weight metabolites
- AVANTE 2023 · Consortium coordinator · Panel: NMR low-molecular-weight metabolites
- HARMONi 2023 · Consortium coordinator · Panel: NMR low-molecular-weight metabolites
Show 7 more Show less
- COST Action AtheroNET 2022 · Consortium partner · Panel: NMR low-molecular-weight metabolites
- CARDIOSCOPE 2022 · Consortium partner · Panel: NMR low-molecular-weight metabolites
- Companion diagnostic for Saroglitazar 2021 · Beneficiary company · Panel: NMR low-molecular-weight metabolites
- Torres Quevedo · Colorectal cancer 2021 · Beneficiary company · Panel: NMR low-molecular-weight metabolites
- VISIONING 2021 · Co-principal investigator, with the IRB CatSud metabolomics platform · Panel: NMR low-molecular-weight metabolites
- Torres Quevedo · Diagnostic metabolomics 2020 · Beneficiary company · Panel: NMR low-molecular-weight metabolites
- Cardiometabolic prediction 2018 · Beneficiary company · Panel: NMR low-molecular-weight metabolites